News
GeoVax to present its plug and play vaccine technology at New York Academy of Sciences Vaccine Conference
The poster presentation will feature GeoVax’s Plug and Play vaccine platform which utilizes its recombinant Modified Vaccinia Ankara (MVA) vector to express foreign antigens on virus-like particles (VLPs) in the person being vaccinated.
GVK BIO, LifeArc celebrate a decade of partnership in transforming research into life-saving medicines
Over the past decade, LifeArc scientific teams have focused on modulating novel targets with therapeutic potential in diseases where there is patient need, with the GVK BIO team assisting in synthesizing complex molecules.
